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To assess the consequences of oxidative stress in
allergic and irritant contact dermatitis, we compared
the iron level, unsaturated iron-binding capacity,
total iron binding capacity, the percentage saturation
of iron-binding capacity, the amount of diene conju-
gates as well as the amounts of total glutathione,
reduced glutathione, oxidized glutathione, and the
oxidized glutathione/reduced glutathione ratio in
skin homogenate from lesional and nonlesional skin.
Lesional skin samples were obtained from positive
patch test sites to 5% NiSO4 in ®ve subjects, and
from chronic contact dermatitis lesions on the
hands, which had exacerbated over 3±9 wk in six
subjects. Contact dermatitis caused at least a 4-fold
increase in the iron level in the lesional skin area
compared with the nonlesional skin area (p < 0.02).
The increase in the iron level depended on the dur-
ation of contact dermatitis and was accompanied by
high unsaturated iron-binding capacity and total
iron-binding capacity values in the positive patch
test sites (p < 0.05), and by a high percentage satur-
ation value in the chronic contact dermatitis lesions
(p < 0.05). We found high indices for iron, total
iron-binding capacity and diene conjugates in the
apparently healthy skin of the patients with persistent
contact dermatitis that signi®cantly (p < 0.05)
exceeded the corresponding values in the patients
with only patch test reactions. In summary, we have
succeeded in providing evidence that generalized
oxidative damage of the skin occurs as a conse-
quence of contact dermatitis in a restricted area.
Key words: diene conjugates/iron-binding capacity/reduced
glutathione. J Invest Dermatol 116:886±890, 2001
T
he skin functions as a biobarrier against hazardous
environmental physical, chemical, and biologic agents.
In¯ammatory reactions triggered by exogenous and
endogenous factors, including free radicals, are
involved in the pathogenesis of dermatologic diseases
(Harman, 1992; Janssen et al, 1993; Darr and Fridovich, 1994;
Picardo et al, 1996; Lopez-Torres et al, 1998; Halliwell and
Gutteridge, 1999).
In allergic and irritant contact dermatitis (ACD, ICD) an array of
reactive oxygen species (ROS) is produced. ROS are set free by
in¯ammatory mediators, generated directly by irritants or allergens
(Corsini and Galli, 1998; Willis et al, 1998), and released during free
radical chain reactions. The main source of ROS is in¯ammatory
cellular in®ltrate. Stimulated monocytes produce superoxide, the
respiratory burst of in®ltrating PMN in in¯amed skin will produce
high local levels of superoxide anion and hydrogen peroxide
(Trenam et al, 1992a; Darr and Fridovich, 1994). Production of
nitric oxide by nitric oxide synthase in keratinocytes also occurs
(Halliwell and Gutteridge, 1999). Excessive production of ROS
results in peroxidation of cell membrane lipids and damages of
proteins and DNA (Bunker, 1992; Pantopoulos and Hentze, 1995;
Picardo et al, 1996).
Iron and oxygen are at a metabolic crossroad where any
mismanagement leads to toxicity, tissue damage, and severe
in¯ammation. Therefore, biochemistry both of ROS and iron
are closely related to each other (Trenam et al, 1992a; Morris et
al, 1995; Halliwell and Gutteridge, 1999). ROS can release iron
from intracellular iron storage protein, ferritin, and trigger a
rapid reduction of ferritin synthesis (Trenam et al, 1992b;
Pantopoulos and Hentze, 1995); and vice versa, iron promotes
the formation of ROS that contribute to lipid peroxidation (LP)
(Morris et al, 1995; Pantopoulos and Hentze, 1995; Van Lenten
et al, 1995).
The skin possesses considerable endogenous protection against
oxidative damage, as it is equipped with several antioxidants
(Vessey et al, 1995; Kerb et al, 1997; Thiele et al, 1997; Kohen,
1999). Reduced glutathione (GSH) has gained attention as the
central cellular antioxidant in the skin (Vessey et al, 1995; Picardo et
al, 1996; Hirai et al, 1997; Shvedova et al 2000) that also participates
in the metabolism of xenobiotics and leukotrine synthesis
(Halliwell, 1994; Hanada et al, 1997). The protective role of
cutaneous GSH against UV injury has been thoroughly investigated
on cultured human skin cells (Punnonen et al, 1991; Vile and
Tyrrell, 1995), in the skin of mice (Hanada et al, 1997; Lopez-
Torres et al, 1998), and in human volunteers (Kerb et al, 1997). The
Manuscript received July 17, 2000; revised February 1, 2001; accepted
for publication March 12, 2001.
Reprint requests to: Dr. Sirje Kaur, Clinic of Dermatology, Tartu
University, Lossi 21/23 51003, Tartu, Estonia. Email:
Sirje.Kaur@kliinikum.ee
Abbreviations: ACD, allergic contact dermatitis; CD, contact dermatitis;
DC, diene conjugates; GSH, reduced glutathione; GSSG, oxidized
glutathione; ICD, irritant contact dermatitis; LP, lipid peroxidation; OS,
oxidative stress; ROS, reactive oxygen species; TGSH, total glutathione;
TIBC, total iron-binding capacity; UIBC, unsaturated iron-binding
capacity.
0022-202X/01/$15.00 ´ Copyright # 2001 by The Society for Investigative Dermatology, Inc.
886
inhibitory role of GSH in contact dermatitis (CD) in mice has been
exempli®ed by Hirai et al (1997).
This study was performed to compare the iron status and
glutathione redox status in ACD and ICD lesions with the values of
apparently healthy skin of the same subjects.
MATERIALS AND METHODS
Patients With permission of the local ethics committee, two 4 mm
skin punch biopsies were taken from 11 study participants under
lidocaine + epinephrine local anesthesia. Lesional skin was biopsied in six
patients (four female, two male, mean age 46.5 y, within the range of
22±84 y) with chronic ICD (three patients) or ACD (three patients) on
their hands, which had exacerbated over 3±9 wk, and at the time of
investigation was characterized by marked erythema, edema, and
vesiculation. Simultaneously, the skin of symmetrical or functionally
comparable unaffected sites was biopsied. These analyzes served to
provide control values. Skin from positive patch test sites to 5% nickel
sulfate was obtained from the backs of ®ve female patients (mean age
35.4 y, within the range of 19±67 y) on the second to the ®fth day after
the application. Positive test reactions were graded as +++ (extensive
in®ltrated erythema with coalescing vesicles) or as ++ (erythema, edema,
and discrete vesicles). Their control biopsies were taken from the back or
¯exor surface of the forearm. For patch testing, the European standard
series (Chemotechnique Diagnostics AB, Sweden) was used. The
investigation was carried out in the wintertime. None of the patients had
received any systemic remedies. The treatment with topical
corticosteroids was stopped 1 wk before skin sampling. No changes in
blood albumin, bilirubin, urea, and hemoglobin content were
established.
Sample preparation Epidermis and dermis together were frozen and
stored at ±80°C until used. Biopsies were kept for 5 d in liquid nitrogen
to produce supernatants whose homogeneity was comparable with
supernatants produced by soni®cation (Lopez-Torres et al, 1998).
Biopsies were carefully homogenized in 1.15% KCl solution with special
homogenizer and centrifuged at 10,000 3 g for 10 min. The
supernatants were kept on ice and used for antioxidant assays.
Level of iron, the unsaturated iron-binding capacity (UIBC), the
total iron binding-capacity (TIBC), and the percentage saturation
of iron-binding capacity For the assessment of these indices a
special kit (Sigma 565, Sigma, St. Louis, MO) was used. All procedures
were performed in triplicate. Brie¯y, for determination of the tissue iron
level 0.250 ml of the tissue homogenate and 1.250 ml Iron Buffer
Reagent (hydroxylamine hydrochloride, 1.5% wt/vol in acetate buffer,
pH 4.5) were mixed, centrifuged for 10 min at 3000 3 g and initial
absorbance was measured at 560 nm. Then 0.025 ml Iron Color
Reagent, which forms water-soluble magneta complex with iron
(Ferrozine 0.85% wt/vol in hydroxylamine hydrochloride solution) was
added, mixed, incubated for 10 min at 37°C and centrifuged for 10 min
at 3000 3 g. Absorbance was measured at 560 nm versus water blank and
the iron concentration was calculated by using a kit formula. Iron
content was expressed as mM per g skin. To determine UIBC of the
tissue 1.000 ml UIBC buffer reagent (TRIZMA, 0.5 M per liter,
pH 8.1), 0.25 ml of the tissue homogenate and 0.25 ml iron kit standard
(0.500 mg per dl) were mixed, centrifuged for 10 min at 3000 3 g and
the initial absorbance was measured at 560 nm. The procedure was
completed as described for total iron determination. UIBC (expressing
the number of free iron-binding sites) was presented in mM per g skin.
TIBC is the sum of iron and UIBC values, and the percentage saturation
indicates the percent of bound iron.
Lipid peroxidation The level of diene conjugates (DC) was
measured as previously described (RistimaÈe et al, 1999). Brie¯y, 0.15 ml
of sample and 0.15 ml 0.9% NaCl (reagent blank contains isotonic saline)
were incubated at 37°C for 30 min. Then 0.25% BHT (0.015 ml) was
added, the samples were extracted with heptane/isopropanol (1:1, whole
volume 1.8 ml) and acidi®ed by 0.5 ml 5 N HCl. After extraction with
cold heptane (1.6 ml), samples were centrifuged (for 5 min at 3000 3 g)
and absorbance of heptane fraction was measured at 234 nm.
Determination of total glutathione (TGSH), oxidized glutathione
(GSSG), and reduced glutathione (GSH) TGSH and GSSG were
measured by the method of Grif®th (1980), which we had slightly
modi®ed. The samples were deproteinated with 10% metaphosphoric
acid (Aldrich, Cat. 43157). To measure glutathione content 0.005 ml
4 M triethanolamine (Aldrich, Steinheim, Germany, Cat T5830-0) in
water was added to the 0.1 ml of protein free sample and immediately
mixed. The sample was diluted with 0.895 ml of 0.2 M sodium
phosphate buffer (pH 7.5) containing 0.01 M ethylenediaminetetraacetic
acid (buffer 1). For determination of GSSG, GSH was derivatized by
adding 0.01 ml of 1 M 2-vinylpyridine (Aldrich, Cat 13229±2) in
ethanol, mixed, and kept at room temperature for 1 h. To assay TGSH
or GSSG, the samples were mixed with 0.5 ml of buffer 1 containing
0.5 U glutathione reductase (Sigma Cat G4751), and 0.3 mM NADPH
(Sigma Cat N7505). Reaction was initiated by the addition of 0.1 ml of
1 mM 5,5,-dithio-bis-(2-nitrobenzoic acid) in buffer 1. The change in
optical density was measured after 10 min at 412 nm. TGSH, GSH, and
GSSG are expressed as mg per g skin. Glutathione redox status was
expressed as GSSG/GSH.
Statistical analysis Statistical analysis was performed using the
Student's t test for unpaired samples. A difference was considered
signi®cant if p < 0.05.
RESULTS
Patients with CD are characterized by increased iron level in
lesional areas of skin One of the features of OS in skin
in¯ammation is altered iron metabolism (Trenam et al, 1992a;
Morris et al, 1995). To evaluate the iron alteration in CD,
comparative studies were carried out in lesional and nonlesional
skin from 11 patients. As shown in Table I, both skin patch testing
Table I. Characteristics of OS in in¯amed and apparently healthy skin
Patients with positive patch test reactionsa Patients with chronic CD on handsb
Apparently healthy skin Patch test site pf Apparently healthy skin Lesional skin pf
Ironc 104 6 9 741 6 396 <0.02 322 6 183 1038 6 493 <0.02
UIBC 157 6 16 888 6 443 <0.05 440 6 226 314 6 233 NSg
TIBC 256 6 21 1629 6 815 <0.05 800 6 203 1319 6 649 NS
% saturation 39 6 1 45 6 8 NS 45 6 22 74 6 11 <0.05
DCd 266 6 97 306 6 102 NS 541 6 156 533 6 210 NS
TGSHe 627 6 400 791 6 209 NS 1442 6 1194 1527 6 1246 NS
GSSG 169 6 61 320 6 121 <0.05 431 6 292 463 6 221 NS
GSH 457 6 442 470 6 191 NS 1011 6 931 1064 6 1156 NS
GSSG/GSH 0.76 6 0.44 0.86 6 0.49 NS 0.65 6 0.33 1.37 6 1.25 NS
aData represent the mean 6 SD in positive patch test sites to 5% NiSO4 in ®ve patients.
bData represent the mean 6 SD in six patients with chronic CD on hands with signs of exacerbation within the last 3±9 wk.
cIron, unbound iron-binding capacity (UIBC), and total iron-binding capacity (TIBC), are expressed as mm per g skin.
dDiene conjugates (DC) are expressed as mm per g skin.
eTotal glutathione (TGSH), oxidized glutathione (GSSG), and reduced glutathione (GSH) are expressed as mg per g skin.
fSigni®cantly different (p < 0.05) by Student's t test.
gNS, not signi®cant.
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and spontaneous CD caused at least a 4-fold increase in iron level in
lesional skin compared with nonlesional area (p < 0.02). In patients
biopsied from positive patch test sites the level of iron in lesional
region was 741 6 396 mM per g skin and in apparently healthy
skin 104 6 9 mM per g skin. UIBC and TIBC values were about
six times higher in the patch test sites compared with healthy skin
(p < 0.05). In chronic CD lesions the iron level was enhanced
compared with the level in uninvolved skin (1038 6 493 and
322 6 183 mM per g skin, respectively, p < 0.02). There were no
signi®cant differences in UIBC and TIBC values, but the
percentage saturation was higher in lesional skin (p < 0.05). All
of these results are presented in Table I.
Increase of iron level in lesional and nonlesional skin
depends on duration of dermatitis The effect of disease
duration on iron status in in¯ammatory skin condition caused by
ACD or ICD is given in Fig 1. The iron level and the percentage
saturation value in lesional skin were higher in the patients with
chronic exacerbated CD in comparison with the data, obtained
from the positive patch test sites. The difference between the
saturation indices was signi®cant (p < 0.05). The UIBC value, on
the contrary, was signi®cantly higher in the patch test areas (p
< 0.05). Surprisingly, in nonlesional skin of the patients with
chronic CD the indices for iron and TIBC were about three times
higher (p < 0.05) as in nonlesional skin of the patients whose skin
symptoms were caused by patch testing and thus were of a shorter
duration (Fig 2). The measured iron was nonhaem iron, as the
control test with red blood cells, treated under the same conditions
as the skin samples, did not result in detectable iron.
DC level does not differ in lesional and nonlesional skin
areas but is increased time-dependently ROS-mediated OS
may induce an increase in iron-caused LP (Bunker, 1992; Trenam
et al, 1992a, b; Morris et al, 1995). To assess LP level in patients
suffering from ACD or ICD, the amount of DC was measured.
The increase of DC level in the positive patch test sites to 5%
NiSO4 in comparison with uninvolved skin of the same patients
was insigni®cant (Table I). Likewise, the comparison of DC levels
in the chronic CD lesions and in the positive patch test sites did not
reveal any signi®cant differences (Fig 1); however, the increase of
DC in nonlesional skin areas was dependent on the duration of CD
(p < 0.05, Fig 2). It is noteworthy that the level of DC in
nonlesional skin area of patients with dermatitis of longer duration
was signi®cantly higher (p < 0.05) in comparison with the values in
the positive patch test sites where the duration of in¯ammation was
only 2±5 d (Table I).
Oxidized glutathione level in CD is increased both acutely
and time-dependently GSSG and glutathione redox status
(GSSG/GSH) are well-known indices for cellular OS. GSSG and
redox status values were increased in the lesional area of skin
compared with the nonlesional skin area (Table I); however, due
to signi®cant individual variability of glutathione amounts a
statistically signi®cant difference was established only for GSSG in
patients biopsied from positive to 5% NiSO4 patch test sites during
the early stage of in¯ammation (Table I). Nonetheless, it should be
underlined that the level of GSSG in the nonlesional skin area of
patients suffering from chronic CD was even higher than in the
positive to 5% NiSO4 patch test sites.
DISCUSSION
In this study, we have provided evidence that CD, restricted to a
small area, is not a local problem as it is often thought to be, but its
consequences are present in whole skin.
CD causes a potent increase of iron level not only in acute or
chronic lesional area, but also in apparently healthy skin. In
prolonged duration of in¯ammation the increase is even more
evident.
Iron is a biologically important trace element. As iron catalyzes
the formation of highly toxic hydroxyl radical, and peroxidation of
lipids, excessive iron is stored in Fe(III) form. In cells, iron is bound
to ferritin, extracellularly to transferrin and lactoferrin, and in
circulation to hemoglobin (Halliwell, 1994; Morris et al, 1995;
Pantopoulos and Hentze, 1995; Van Lenten et al, 1995). The iron
measured in our samples was nonhaemic (mainly ferritin iron) as
the control test with red blood cells, treated under the same
conditions as skin samples, did not result in detectable iron. The
possibility that some of the iron is of hemosiderin and low-
molecular weight chelators origin, in chronic in¯ammation in
particular, cannot be excluded.
The high iron content in lesional skin might be explained by
in¯ammation-induced OS. A chronic exposure of hairless mice to
low levels of UVB has been reported to have increased the
nonhaem iron content of the skin (Bissett et al, 1991). Trenam et al
(1992b) have shown that intradermal injection of H2O2-producing
enzyme glucose oxidase rapidly produces a cellular in®ltrate of
monocytes and neutrophils, and signi®cantly increases the levels of
iron in the skin of rats both with or without prior iron loading.
Despite not being species-speci®c, these is the best evidence of
in¯ammation-induced changes in iron content of the skin so far.
In CD at least four potential mechanisms involved in storage and
reduction of Fe(III) to Fe(II) may contribute to the rise of iron. (i)
The mobilization of redox active iron from storage protein, e.g.,
ferritin, is related to the oxidative burst of in®ltrating PMN with
Figure 1. Changes in iron status of CD lesions depending on the
duration of in¯ammation. Skin punch biopsies were taken from
positive to 5% NiSO4 patch test sites in one group of the patients (open
bars), and from chronic CD lesions on the hands in another group of
patients (closed bars). We identi®ed a signi®cantly higher UIBC value in
the positive patch test sites and higher percentage saturation values of
iron-binding capacity in the patients with chronic exacerbated CD. The
difference in the DC quantities was statistically not signi®cant. The data
shown are mean 6 SD. * p < 0.05,** p < 0.1.
Figure 2. Chronic restricted CD in¯uencing the iron status of
apparently healthy skin. Control biopsies were obtained from
apparently healthy skin of patients with positive to 5% NiSO4 test
reactions (open bars), and from apparently healthy skin of patients with
chronic CD that had become exacerbated during the last 3±9 wk (closed
bars). In the normal skin of the patients with chronic CD, the iron
concentration, the TIBC level, and the DC quantities were signi®cantly
higher in comparison with the normal skin values in the patients with
only patch test reactions. The difference in the GSSG values was not
signi®cant. The data shown are mean 6 SD. *p < 0.05, **p < 0.1.
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superoxide radicals formation, and degradation of ferritin in
macrophages (Trenam et al, 1992a; Morris et al, 1995). (ii)
In¯ammatory mediators (e.g., TNF-a and IL-1) generated by
monocytes and keratinocytes under the in¯uence of irritants and
allergens (Barker et al, 1991; Howie et al, 1996) or staphylococcal
superantigens in chronic lesions (Leung et al, 1998), and ROS
themselves bring about an increase in the iron-containing acute
phase reactants such as ferritin and lactoferrin (Morris et al, 1995).
(iii) Acidic pH in the activated phagocytes and on the skin may
contribute to the release of active iron (Trenam et al, 1992a). (iv)
In¯ammation-induced hyperproliferation of keratinocytes (Barker
et al, 1991) may increase the epidermal excretion of iron (Trenam et
al, 1992a; Morris et al, 1995).
In acute in¯ammation, the values re¯ecting sequestered iron
(UIBC) and possible total binding capacity of sequesters (TIBC)
were high in the tissue samples in our study. Furthermore, the
increase of iron in the patch test sites concurred with the increase in
UIBC, indicating a rapid response to in¯ammation. Chronic CD
was characterized by an elevated percentage saturation value
showing that more iron-binding sites are occupied with iron. In
addition, restricted to the hands chronic CD in¯uenced the iron
status in whole skin, evidenced by high TIBC values in the
apparently healthy skin of our patients. Therefore, it can be stated
that the iron level response to dermatitis involves whole skin, i.e., it
is of a generalized nature.
The presence of considerable amounts of PUFA in the skin
makes it particularly vulnerable to ROS (Trenam et al, 1992b),
especially in the case of in¯ammation when excessive formation of
ROS occurs. Some studies have reported signs of LP in a model of
human skin (Podda et al, 1998), in the skin of mice with ICD and
ADC (Hirai et al, 1997), and after UV irradiation of cultured
keratinocytes (Punnonen et al, 1991; Stewart et al, 1996).
Lipoperoxidation of skin surface lipids has also been described
(Giralt et al, 1996). We could not establish a statistically signi®cant
difference in the quantities of DC between the in¯amed and the
apparently healthy skin of the same subject; however, the level of
DC was dependent on the duration of the disorder. This was less
obvious between lesions of acute versus chronic CD, but statistically
signi®cant in apparently healthy skin. As the consequence of
chronic in¯ammation, the level of DC in the unaffected skin of
patients suffering from chronic CD was signi®cantly higher even in
comparison with the values in lesions of acute CD (patch test sites).
It refers to the fact that an increased iron level is accompanied by
increased LP and continuous in¯ammation, even if in¯ammation is
restricted to such a small area as the hands, will result in potently
oxidatively stressed whole skin.
ROS biochemistry and both iron (possible pro-oxidant) and
glutathione (scavenger of ROS) biochemistry are known to be
intimately related. The observation that localized CD causes a
generalized OS is further supported by our data about glutathione.
Glutathione is the most abundant low molecular weight antiox-
idant in the skin (Fuchs et al, 1989; Hirai et al, 1997). It is postulated
that in most tissues the amount of GSH greatly exceeds the level of
GSSG (Hall, 1999), but the exact relationship of GSH and GSSG in
the skin remains to be established. Many factors (physical stress,
consumption of supplements, etc.) in¯uence the GSSG/GSH ratio
but in the skin, the outer cover of the body, it is in¯uenced
additionally by many exogenous factors. On exposure to externally
applied oxidizing agents or thiol-reactive toxins, the consumption
of GSH may increase dramatically (Hall, 1999). Exposure of human
keratinocytes to paraphenylene diamine decreases the level of GSH
in a dose- and time-dependent manner (Picardo et al, 1996). Hirai
et al (1997) have provided evidence that a decrease of glutathione
and free sulfydryl-groups in the skin of mice with experimentally
induced ICD and ACD after challenge with dinitrochlorobenzene
may occur because of the conjugation of this allergen with GSH.
Recently, Shvedova et al (2000) reported a decrease of the GSH
content in cultured human keratinocytes exposed to phenol and
suggested that the decrease of GSH may either be due to direct
oxidation by phenoxyl radicals or result from consumption in GSH
peroxidase-catalyzed reactions. For these reasons we believe that
the detected 2±4-fold difference in favor to GSH in our study
re¯ects the real situation in the nonlesional skin of CD patients.
During chronic in¯ammation, the generation of ROS may
become damaging (Halliwell, 1994). In this context, the low
GSSG/GSH ratio in our patients may be accounted for by the study
groups compared, both consisting of CD patients: an asymptomatic
group and a symptomatic group. Besides, the level of glutathione
reductase in the course of differentiation of cultured human
keratinocytes is known to decrease (Vessey et al, 1995), reducing
the GSH regeneration.
Nevertheless, the glutathione system reacts ef®ciently with ROS
generated by dermatitis. (i) We found a signi®cant increase of the
GSSG level only in the positive to 5% NiSO4 patch test sites, i.e., in
short-time CD. (ii) Although chronic CD caused an increase of
GSSG levels in lesional as well in apparently healthy skin indicating
to the severity and generalized nature of OS, these differences were
because of a concomitant increase of the GSH values below
statistical signi®cance.
Skin disease, especially when restricted to a small area, is often
considered to be a local problem. For that reason, it may be of
particular interest to evaluate the degree of OS in urticaria, where
the ability of the skin to respond to the stimulus as a uniform organ
is much more obvious. Further research may be directed to the
improvement of the skin antioxidative capacity by the adding of
topical and systemic antioxidants and iron chelators to the
treatment schedule of patients with CD that might facilitate a
faster and more complete improvement of the patient's state. In
summary, we have provided evidence that generalized severe OS of
the skin is expressed as a consequence of CD in a restricted area.
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